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Abstract
Background: In Colombia, Plasmodium falciparum infection rarely results in severe disease or mortality compared
to infections in African populations. During natural infection NK cells exhibit a cytolytic effect and regulate
dendritic cells, macrophages, neutrophils as well as affect antigen specific T and B cell responses. To characterize
the NK cells in P. falciparum infected patients of a highly endemic region of Colombia, the degree of NK
proliferation and production of IFN gamma and TNF production in these cells were explored.
Methods: Seventeen patients with acute and three with severe P. falciparum malaria patients from the Northwest
region of the country were recruited in the study. In addition, 20 healthy controls were included: 10 from Medellin
(no-transmission area) and 10 from the Uraba region (a malaria endemic area). Immunophenotypic analysis of
peripheral mononuclear cells was performed by FACS to detect total number of NK cells, subtypes and intracellular
IFNg and TNF production by NK cells in the different patient groups.
Results: The total mean CD56
+/CD3
- NK cell proportions in acute and severe malaria subjects were 9.14% (7.15%
CD56
dim, 2.01%CD56
bright) and 19.62% (16.05%CD56
dim, 3.58%CD56
bright), respectively, in contrast to healthy
controls from endemic (total mean CD56
+/CD3
-1.2%) and non-endemic area (total mean CD56
+/CD3
- 0.67%).
Analysis of basal IFNg and TNF levels confirmed the CD56
bright NK population as the main cytokine producer (p <
0.0001) in the groups affected with malaria, with the CD56
dim NK cell exhibiting the highest potential of TNF
production after stimulus in the acute malaria group.
Conclusions: The results confirm the important role of not only CD56
bright but also of CD56
dim NK cell populations
as producers of the two cytokines in malaria patients in Colombia.
Background
The clinical presentation of malaria depends on the con-
fluence of diverse factors, including the degree of nat-
ural and acquired specific immunity, host’s genetic
composition, age, occupation and social and economic
factors of the population [1].
M a l a r i ai nC o l o m b i ai sh i g h l ye n d e m i ci nt h en o r t h -
west, Pacific Coast and Amazon regions, all among the
most deprived of the country due to social-political
conflicts resulting in migrations and poverty. Previous
studies in the northwest of Colombia, confirmed that
children below 12 years of age are highly susceptible to
malaria with a mean seven years of age for clinical pre-
sentation with malaria [2]. About 70% of this young
population was affected by chronic malnutrition and
85% with intestinal parasitism, two conditions with
important effects on the immune fitness of malaria
affected individuals [2,3].
Despite the high frequency of Plasmodium falciparum
infection, severe or fatal malaria cases are rare in the
country. Out of the 79,909 malaria cases (72% Plasmo-
dium vivax-27% P. falciparum) reported in 2009, 307
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rate was 0.04%[4]. This is in striking contrast to reports
from African populations, where around 0.4% mortality
rates were reported in the same year, most of them in
children under 5 years of age [5]. In Colombia, is the
20-24 age group the most frequently affected by malaria,
with around 15% of total cases, followed by the 15-19
age group (around 14%) and the 10-14 age group
(around 12%). For severe malaria, the most commonly
affected groups is the 20-24 age group (around 21%)
and the 15-19 age group (around 13%)[6]. This is evi-
dence of a clear-cut difference in the age pattern of
severe malaria presentation between Colombia and Afri-
can countries.
For many years, the importance of effective acquired
immune response to protect against severe P. falci-
parum infection has been known. In this sense, both
innate and adaptative immune responses, constitute a
key component in subsequent Plasmodium challenges
by reducing parasitaemia during the acute phase of the
disease [7]. After infection with a microorganism, nat-
ural killer (NK) cells lymphocyte lineage cells exhibit a
cytolytic effect, which, can directly induce the death of
infected cells in absence of specific immunization. Sub-
sequently, NK cells have been recognized as major pro-
ducers of interferon-g (IFN-g)a n do t h e rc y t o k i n e s ,
either pro-inflammatory or anti-inflammatory, including
tumor necrosis factor (TNF), interleukin (IL)-10, and
growth factors such as GM-CSF (granulocyte macro-
phage colony-stimulating factor), G-CSF (granulocyte
colony stimulating factor), and IL-3. NK cells also
secrete many chemokines, including CCL2 (MCP-1),
CCL3 (MIP1-a), CCL4 (MIP1-b), CCL5 (RANTES),
XCL1 (lymphotactin), and CXCL8 (IL-8) [8].
The evidence gathered so far confirms that NK cells
can positively [9,10] or negatively [11] influence the
host’s T and B cell immunity, depending on the nature
of the antigenic challenge. Therefore, in addition to
their cytolytic effect, NK cells can also regulate dendritic
cells, macrophages, neutrophils [12] and affect antigen
specific T and B cell responses [13]. According to the
expression density of CD56, NK cells can be divided
into CD56
dim representing the vast majority of human
NK cells and a small distinct population of CD56
bright
NK cells [14,15]. Almost all CD56
bright NK cells fail to
express CD16 and exhibit a weak cytotoxic activity. In
healthy humans, CD56
bright cells comprise up to 10% of
all NK cells. Granules of CD56
dim cells are richer in per-
forin and granzyme A, which results in a more effective
cytolysis compared to CD56
bright NK cells. However,
CD56
bright NK cells are more efficient in producing the
pro-inflammatory cytokines IFNg and TNF [16].
The presence of severe malaria has been strongly
attributed to an exaggerated immune response of the
host towards parasite antigens and several authors
reported on the positive correlation between high TNF
production and cerebral malaria in humans as well as in
animal models [17]. Parasite genetic diversity does not
seem to influence TNF-mediated effects on the viru-
lence of primary rodent malaria infections [18]. Recent
studies on naïve volunteers confirmed the contribution
of NK cells to total IFNg production and the existence
of memory responses to parasitized erythrocytes [19].
Based on the limited and controversial knowledge on
the function of NK cells during the inflammatory pro-
cess leading to severe malaria and the important role of
TNF and IFNg in the pathogenesis of the complicated
disease, the study proposed to correlate the production
of pro-inflammatory cytokines by these cells and their
subsets, and the clinical outcome in malaria patients in
Colombia. The characteristics of NK cells in P. falci-
parum-infected patients of a highly endemic region of
Colombia are described. In addition, the degree of NK
proliferation and production of IFNg and TNF produc-
tion by these cells was explored, with the aim of provid-
ing a first glimpse into their profile in naturally-infected
populations on this continent.
Methods
Subject enrolment
The study took place in Medellin-Colombia, where
patients from the northwest region of the country
attended the malaria clinic of Grupo Salud y Comuni-
dad, Universidad de Antioquia. A total of 23 acute
(non-severe) and seven severe P. falciparum malaria
patients were recruited. Individuals were included
immediately after diagnosis of P. falciparum infection
was performed by microscopy. Inclusion criteria for this
group were: permanent residency in the endemic area,
presence of symptomatic malaria and absence of clinical
viral infections within 2 months of attendance to the
malaria clinic. The degree of clinical impairment was
assessed by an experienced medical officer. Patients
were classified as having acute malaria or severe malaria
according to the WHO criteria[20]. Concomitant infec-
tion with other agents was excluded by clinical evalua-
tion and completion of a questionnaire. In addition, 20
healthy controls were included: 10 from Medellin (non-
transmission area) and 15 from the Uraba region
(malaria-endemic area). Controls were recruited after
exclusion of acute disease or infection by physical exam-
ination and completion of a questionnaire, which was
also used to out rule previous history of malaria. Inclu-
sion criteria for this group were permanent residency in
Medellin or the endemic area, absence of symptomatic
malaria and any clinically apparent viral infection within
2 months of inclusion. Companions attending the
malaria clinics in endemic and non-endemic areas were
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study.
Volunteers were notified of the risks and their rights
and enrolled after providing informed consent. Ethical
clearance was granted by the Ethics Committee of the
Centro de Investigaciones Medicas, Faculty of Medicine,
Universidad de Antioquia (Medellin-Colombia).
Microscopy for Plasmodium detection
Giemsa-Field stained thick/thin blood films were exam-
ined with a 100× objective to identify presence of para-
sites, Plasmodium species, parasite density, and
schizontaemia. Parasite density was measured by count-
ing the number of asexual parasites per 200 leukocytes,
based on a mean count of 8,000 leukocytes per microli-
tre of blood (theoretical value). A slide was considered
negative after examination of at least 300 microscopic
fields [21].
Isolation of peripheral mononuclear cells
Blood samples from volunteers were obtained from per-
ipheral vein and, in the case of malaria subjects, before
malaria treatment was administered. Samples of 16 mL
were collected into EDTA vacutainer vials from patients
and controls and peripheral blood mononuclear cells
were separated by density centrifugation (Ficoll-Hypaque
1077). Mononuclear cells were collected from the inter-
face, washed twice by centrifugation with EDTA-PBS at
640 g and 160 g, respectively, for 10 min at 4°C. Cells
were then suspended in complete RPMI 1640 medium
buffered with 25 mM Hepes and supplemented with 12
mM sodium bicarbonate, 2 mM L-glutamine, 100 U/mL
penicillin, 100 mg/mL streptomycin and 5% foetal
bovine serum. Cell viability was assessed with 0.1% try-
pan blue in PBS pH 7.3.
Flow cytometry
Immunophenotypic analysis of cells was performed
using four-colour analysis on a FACSCalibur (Becton
Dickinson, San Jose, CA) with CELLQuest Pro software
(Becton Dickinson). Cells were stained with the follow-
ing monoclonal antibodies: fluorescein isothiocyanate
(FITC)-conjugated anti-CD56 (SIGMA) and Cychrome
(Cy)-anti-CD3 (SIGMA) to determine the percentage of
NK cells within the sample. Gating was performed
according to size and granulation using forward-scatter
versus side-scatter (FSC/SSC) dot plots.
Production of INFg and TNF by NK cells was deter-
mined by flow cytometry. For this, 10
6 freshly isolated
mononuclear cells per well were incubated with phorbol
myristate acetate (PMA) 10 mg/ml plus calcium iono-
phore 250 ng and brefeldin A 0.4 mg/mL for 6 h at 37°
Ci n5 %C O 2. Analysis included a description of the
total NK cell and subtypes populations according to
IFNg and TNF production in the different groups of
study: acute malaria, severe malaria, and healthy volun-
teers from endemic and non-endemic area. Results were
processed using Prisma
®, and mean values and standard
deviations were compared using t-student.
Results
Natural killer population analysis in the malaria affected
group was successfully performed in 17 acute malaria
and three severe malaria volunteers. Samples from 10
subjects from Medellin (non-endemic) and 10 from
Uraba (endemic region) were processed as controls.
The male/female ratio in the experimental group was
16/4 and the age ranged from 18 to 59 years old (mean 34
± 14). The male/female ratio in the controls was 13/7 and
the age ranged from 18 to 49 years old (mean 33.3 ± 9.9).
Among the patients with acute malaria, the most common
symptoms were fever (100%), chills (88%) and sweating
(47%), while other complaints such as diarrhoea and
vomiting were rare. Parasitaemia in these patients ranged
between 80 and 9,440 rings/mm
3 (mean 5,640 ± 2,281).
All patients with severe malaria reported fever, chills,
sweating, general malaise, headache, vomiting, two
reported dizziness and one had abdominal pain. Parasitae-
mia in each of these patients was 154,000, 171,000 and
195,000 rings/mm
3 (mean 173,500 rings/mm
3). The diag-
nosis of severe malaria was based on the high number of
vomiting episodes per day and hyperparasitaemia.
NK cell population distribution
In acute malaria-infected patients, the total CD56
+/CD3
-
NK cell population was 9.1 ± 0.3% of which 7.1 ± 0.4%
were CD56
dim and 2.0 ± 0.2% were CD56
bright.M e a n -
while, in patients with severe malaria, the total popula-
tion of CD56
+/CD3
- was 19.6 ± 0.6% and the mean
CD56
dim and CD56
bright populations were 16.0 ± 0.3%
and 3.6 ± 0.9%, respectively. These proportions of NK
cells in acute malaria-infected and severe patients were
statistically similar. After PMA and calcium ionophore
addition, cells from complicated malaria patients showed
higher levels of both CD56
dim and CD56
bright populations
when compared to acute malaria patients (see Figure 1).
The mean CD56
+/CD3
- population in healthy volun-
teers from a malaria endemic area was 1.2 ± 0.6% and
in healthy volunteers from the non-endemic area the
mean was 0.7 ± 0.2%. The low numbers of NK cells in
these two control groups, made discrimination between
CD56
dim and CD56
bright populations not feasible due to
particular ethical constraints of the project to obtain the
large volume of blood required to perform such analysis.
Intracellular IFNg production
NK cells were responsible for 2.4% of the total IFNg
production in subjects with acute malaria, and this
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6.64% observed in severe malaria patients. A mean 76.7
± 2.3% of NK cells from acute malaria patients produced
IFNg. In patients with severe malaria, 94.6 ± 2.4% of NK
cells were IFNg producers. After stimulus, the propor-
tion of IFNg-producing NK cells increased to 96.4 ±
3.5% in acute malaria patients and to 99.0 ± 3.6% in
severe malaria patients. In controls from endemic and
non-endemic areas, baseline proportion of IFNg produ-
cing cells was 0.2 ± 1.1% and increased to 2.5 ± 0.3%
after stimulus, in all cases significantly lower than
infected subjects. Representative dot plots of these
results are presented in Figure 2.
Analysis of basal IFNg production according to the
CD56
dim or CD56
bright phenotype confirmed that in
both acute malaria and in severe malaria subjects, the
CD56NK
bright population produced significantly higher
levels of cytokine (p < 0.0001) than the CD56
dim popula-
tion (Figure 1a-b). On the other hand, after 6 hours of
stimulus with calcium ionophore, CD56
dim cells from
malaria-infected patients produced the highest levels of
IFNg regardless of their clinical presentation.
Intracellular TNF production
The proportion of NK cells producing TNF in acute
malaria subjects under basal conditions was 70.3 ± 2.1%.
This proportion was significantly lower compared to the
92.5 ± 2.6% observed in severe malaria subjects. The
proportion of TNF-producing NK cells rose to > 97%
after stimulus in the two groups. Controls from endemic
and non-endemic areas exhibited a significant < 0.3% of
TNF producing cells, in comparison with infected
subjects, either before or after stimulus. Analysis of
basal TNF production according to the CD56
dim or
CD56
bright phenotype confirmed that in acute malaria
subjects, as well as in severe malaria, the CD56
bright
population produced significantly higher levels of the
cytokine (p < 0.0001) than the CD56
dim population (Fig-
ure 1d-e). However, after 6 hours of stimulus with cal-
cium ionophore, CD56
dim cells from acute malaria and
from severe malaria subjects produced significantly
higher levels of TNF (Figure 1f).
Discussion
Early events of the immune response against pathogens
involve the activation of the innate arm of immunity,
which then regulates the subsequent adaptative immune
response required to control infection [22]. For many
years, NK cells have been proposed to play a significant
role in clearance of protozoan parasites [23,24] including
blood-stage malaria parasites [25], due to their early
activation after infection. Upon contact with infected
cells, NK cells proliferate and release cytokines by a
complex system of triggering and inhibitory molecules
[26,27]. They recognize major histocompatibility com-
plex (MHC) class I molecules via membrane receptors
that deliver inhibitory signals of NK-cell cytotoxicity. If
target cells lack or express insufficient density of MHC
class I molecules, as occurs during infection, cytotoxicity
takes place. NK cell-mediated cytotoxicity occurs mainly
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Figure 1 Proportions of cytokine producing natural killer cells
according to clinical status. Acute malaria vs. severe malaria
subjects under basal conditions, 6 h after culture (+6 hr) and 6 h
after culture plus stimulation with PMA, calcium ionophore Brefeldin
A (+6 hr and stimulus). The proportions of IFNg producing CD56
dim
(a) and CD56
bright (b) cells, proportions of TNF producing CD56
dim
(d) and CD56
bright (e) cells. IFNg (c) and TNF (f) production by total
NK cell population were assessed in healthy controls from endemic
and non-endemic regions.
Figure 2 Representative dot plots demonstrating the method
of gating of CD56 cell and subsets and the production of
cytokines according to clinical status. A comparison of non-
stimulated total CD56 cells collected from a typical uninfected
control (Panels 1 a-d) and CD56
dim-CD56
bright cells from a malaria
infected subject (Panels 2 a-h), is presented. Numbers in the
quadrant represent percent of cytokine cell producing cells (1a, 1c,
2a, 2c, 2e, 2g) and proportion of the cytokine produced by a
particular cell subset (1b, 1d, 2b, 2d, 2f, 2h).
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preformed granules containing perforin and granzymes
in the intercellular space, leading to the lysis of target
cells within minutes [28].
NK cells are among the first lymphocytes to respond
to P. falciparum-infected red cells by producing IFNg as
evidenced by in vitro [29,30] and in vivo studies [31].
Moreover, exposure of naïve volunteers to a single
malaria P. falciparum infection was able to induce
robust and lasting cellular responses of both T and NK
cells [19]. Studies on the dynamics of NK activity in
malaria patients revealed heterogeneous results, particu-
larly in P. falciparum infected individuals. Nevertheless,
confirmation of NK activation has been observed in sub-
jects with Plasmodium vivax or P. falciparum infection
[32].
This study detected increased NK cell population in
all infected subjects, with similar proportions both
CD56
dim and CD56
bright populations, and, albeit the low
number of individuals, this seemed marked in severe
malaria cases. Other authors have demonstrated a simi-
lar pattern of NK increase in both CD56
dim and
CD56
bright after controlled challenge with P. falciparum,
reporting an increase of around 12% in NK cells during
acute infection [19]. Kassa et al. [33] reported normal
NK cell counts in P. falciparum or P. vivax malaria.
However, other researchers have reported lower counts
of NK cells, and other lymphocytes, in a Plasmodium
berghei murine model [34] and during acute P. falci-
parum malaria [35-37]. These conflicting results might
be due to differences in the baseline values of the abso-
lute counts of the immune cells of the subjects of study.
Alternatively, an impact of different geographical loca-
tions which has been suggested by other authors, might
account for such diverse results [34].
The increased of the NK population proportions dur-
ing acute and, probably, during severe malaria described
in this study, in addition to a positive correlation
between NK cytotoxicity and levels of parasitaemia
reported by other authors in patients infected with P.
falciparum [32], confirms the induction of robust cellu-
lar responses to P. falciparum in naturally infected indi-
viduals form the American continent, and highlights the
importance of further exploring the role of these cells
and theirs subsets in the immunopathology during
severe malaria outside Africa.
Activated cells belonging to the two arms of immunity
(innate and adaptative) can produce IFN-g.I nm a l a r i a ,
the main cellular sources of the cytokine are T cells, gδ
T cells, and NK cells. However, in some subjects, there
is little or no evidence of an NK cell response after
exposure to P. falciparum-infected erythrocytes, whereas
in other individuals, NK cells comprise around 70% of
IFNg-producing cells [29,38].C o n t r o v e r s i a lf i n d i n g s
were recently reported on naïve subjects infected with P.
falciparum, in whom NK cells represented, on average,
14% of IFNg-producing cells before challenge, rising to
17% immediately after inoculum and by week 20 post-
infection, represented only 7%, when T cells reached a
peak of production of the cytokine [19]. Such propor-
tions of IFNg-producing cells are very high compared to
the results presented here in all groups of subjects
regardless of the presence of infection: 2.43% in acute
and 6.64% in severe malaria vs. 0.22% in controls, and
might reflect the heterogeneity of innate immune
responses between donors, and/or populations [30,38]
with crucial influencing factors such as type of nutrition
[39], among other. Although the effects of the age on
these results is possible, the authors consider this unli-
kely since the groups were homogenous in age and the
severe malaria subjects also belonged to the most fre-
quently malaria affected age range in the country. Exis-
tence of non-homogenous immune responses is
supported by evidence of different strength co-stimula-
tory signals from myeloid accessory cells and poly-
morphism among NK regulatory receptors [40,41]. In
addition, many reports confirm the requirement of IL-2
as a contributor of IFNg production by NK cells [19,42].
However, recent reports on pregnant mothers revealed
that NK cells are a major source of IFNg when exposed
to P. falciparum antigens in vitro in the absence of any
other co-stimulant. Future in vivo studies in populations
affected with malaria should explore the significance of
IL-2 on the production of IFNg at early stages of infec-
tion and in subjects with different degree of previous
exposure to malarial antigens.
TNF is involved in the immune response to malaria as
well as in the pathogenesis of severe disease[43,44]. Dys-
regulation and imbalance of this and other pro-inflama-
tory cytokines (TNF, IFN-g, IL-12) versus anti-
inflammatory cytokines (IL-4, IL-6, transforming growth
factor-1 beta, TGF-1b) appear to be the main mechan-
isms resulting in the bias towards effective immune
actions or tissue damage in the host [45]. The status of
TNF in the context of NK cell activation was explored
in the current study since these cells have been reported
to be early producers of the cytokine after infection.
The present results confirmed high levels of TNF-pro-
ducing NK cells in acute and severe malaria patients,
with CD56
bright cells exhibiting the highest production
of the cytokine in both infected groups.
Conclusions
The results confirm the important role of not only
CD56
bright but also of CD56
dim NK cell populations as
producers of the two cytokines in naturally infected
malaria patients in Colombia. Future studies should
include exploration of the status of activation of other
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cells in infected patients with malaria by P. vivax and P.
falciparum exhibiting different clinical presentations.
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